Cargando…
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
Cancer cells initially characterized as sensitive to chemotherapy may acquire resistance to chemotherapy and lead to tumor recurrence through the expansion of drug-resistant population. Acquisition of drug resistance to conventional chemotherapy is a major obstacle in the treatment of recurrent canc...
Autores principales: | Lu, Chia-Sing, Shieh, Gia-Shing, Wang, Chung-Teng, Su, Bing-Hua, Su, Yu-Chu, Chen, Yi-Cheng, Su, Wu-Chou, Wu, Pensee, Yang, Wen-Horng, Shiau, Ai-Li, Wu, Chao-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458172/ https://www.ncbi.nlm.nih.gov/pubmed/27244887 http://dx.doi.org/10.18632/oncotarget.9602 |
Ejemplares similares
-
The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Su, Yu-Chu, et al.
Publicado: (2021) -
Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer
por: Lu, Chia-Sing, et al.
Publicado: (2020) -
Prothymosin α overexpression contributes to the development of pulmonary emphysema
por: Su, Bing-Hua, et al.
Publicado: (2013) -
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
por: Feng, Yin-Hsun, et al.
Publicado: (2019) -
Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
por: Su, Bing-Hua, et al.
Publicado: (2015)